My bookmarksSign up free

Commission Regulation (EC) No 1041/2006 of 7 July 2006 amending Annex III to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards monitoring of transmissible spongiform encephalopathies in ovine animals (Text with EEA relevance)

Commission Regulation (EC) No 1041/2006 of 7 July 2006 amending Annex III to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards monitoring of transmissible spongiform encephalopathies in ovine animals (Text with EEA relevance)

Regulation (EC) No 1041/2006 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Annex III to Regulation (EC) No 999/2001 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In Part II of Annex III to Regulation (EC) No 999/2001 points 2 and 3 of Chapter A are replaced by the following: ‘2.   Monitoring in ovine and caprine animals slaughtered for human consumption (a)   Ovine animals Member States shall test healthy slaughtered ovine animals in accordance with the minimum sample sizes listed in Table A of this point and the sampling rules set out in point 4. Table A Member State Minimum sample size in healthy slaughtered ovine animals  ( 1 ) Germany 37 500 Greece 23 000 Spain 41 800 France 42 400 Ireland 40 500 Italy 43 700 the Netherlands 23 300 Austria 14 300 Poland 23 300 Portugal 14 300 United Kingdom 44 000 Other Member States all By way of derogation from the minimum sample sizes listed in Table A Cyprus may decide to test only a minimum of two ovine animals sent for slaughter for human consumption from every flock where no TSE cases have been registered. (b)   Caprine animals Member States shall test healthy slaughtered caprine animals in accordance with the minimum sample sizes listed in Table B of this point and the sampling rules set out in point 4. Table B Member State Minimum sample size in healthy slaughtered caprine animals  ( 2 ) Greece 20 000 Spain 125 500 France 93 000 Italy 60 000 Cyprus 5 000 Austria 5 000 Other Member States all (c)   Where a Member State experiences difficulty in collecting sufficient numbers of healthy slaughtered ovine or caprine animals to reach its allotted minimum sample size established in points (a) and (b), it may choose to replace a maximum of 50 % of its minimum sample size by testing dead ovine or caprine animals over the age of 18 months at the ratio of one to one and in addition to the minimum sample size set out in point 3. In addition a Member State may choose to replace a maximum of 10 % of its minimum sample size by testing ovine or caprine animals killed in the framework of a disease eradication campaign over the age of 18 months at the ratio of one to one. 3.   Monitoring in ovine and caprine animals not slaughtered for human consumption Member States shall test in accordance with the sampling rules set out in point 4 and the minimum sample sizes indicated in Table C and Table D, ovine and caprine animals which have died or been killed, but which were not: — killed in the framework of a disease eradication campaign, or — slaughtered for human consumption. Table C Member State population of ewes and ewe lambs put to the ram Minimum sample size of dead ovine animals  ( 3 ) > 750 000 20 000 100 000 -750 000 3 000 40 000 -100 000 100 % up to 1 000 < 40 000 100 % up to 200 Table D Member State population of goats which have already kidded and goats mated Minimum sample size of dead caprine animals  ( 4 ) > 750 000 10 000 250 000 -750 000 3 000 40 000 -250 000 100 % up to 1 000 < 40 000 100 % up to 200 ( 1 )   Minimum sample sizes are set to take account of the size of the number of healthy slaughtered ovine animals and are intended to provide achievable targets. The minimum sample sizes above 30 000 allow the detection of a prevalence of 0,003 % with a 95 % confidence. ( 2 )   Minimum sample sizes are set to take account of the size of the number of healthy slaughtered caprine animals and the prevalence of BSE in the individual Member State. They are also intended to provide achievable targets. The minimum sample sizes above 60 000 allow the detection of a prevalence of 0,0017 % with a 95 % confidence. ( 3 )   Minimum sample sizes are set to take account of the size of the ovine and caprine populations in the individual Member States and are intended to provide achievable targets. ( 4 )   Minimum sample sizes are set to take account of the size of the ovine and caprine populations in the individual Member States and are intended to provide achievable targets.’

Other acts of the same type
Commission Implementing Regulation (EU) 2024/357 of 23 January 2024 imposing a definitive anti-dumping duty on imports of certain open mesh fabrics of glass fibres originating in the People’s Republic of China as extended to imports consigned from India, Indonesia, Malaysia, Taiwan and Thailand following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and the CouncilCommission Delegated Regulation (EU) 2024/369 of 23 January 2024 supplementing Directive (EU) 2020/2184 of the European Parliament and of the Council by laying down the procedure regarding inclusion in or removal from the European positive lists of starting substances, compositions and constituentsCommission Delegated Regulation (EU) 2024/370 of 23 January 2024 supplementing Directive (EU) 2020/2184 of the European Parliament and of the Council by laying down conformity assessment procedures for products that come into contact with water intended for human consumption and the rules for the designation of conformity assessment bodies involved in those proceduresCommission Delegated Regulation (EU) 2024/371 of 23 January 2024 supplementing Directive (EU) 2020/2184 of the European Parliament and of the Council by establishing harmonised specifications for the marking of products that come into contact with water intended for human consumptionCommission Regulation (EU) 2024/341 of 22 January 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for diethofencarb, fenoxycarb, flutriafol and pencycuron in or on certain productsCommission Regulation (EU) 2024/342 of 22 January 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyflumetofen, oxathiapiprolin and pyraclostrobin in or on certain productsCommission Regulation (EU) 2024/344 of 22 January 2024 amending and correcting Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for mandipropamid in or on certain productsCommission Regulation (EU) 2024/345 of 22 January 2024 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for desmedipham, etridiazole, flurtamone, profoxydim, difenacoum and potassium permanganate in or on certain productsCommission Regulation (EU) 2024/346 of 22 January 2024 amending Annex II to Regulation (EC) No 1333/2008 of the European Parliament and of the Council and the Annex to Commission Regulation (EU) No 231/2012 as regards the use of trimagnesium dicitrate in food supplementsCommission Regulation (EU) 2024/347 of 22 January 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fipronil in or on certain productsCommission Regulation (EU) 2024/352 of 22 January 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for (Z)-13-hexadecen-11-yn-1-yl acetate, (Z,Z,Z,Z)-7,13,16,19-docosatetraen-1-yl isobutyrate, acrinathrin, azimsulfuron, famoxadone, prochloraz and sodium hypochlorite in or on certain productsCouncil Implementing Regulation (EU) 2024/362 of 22 January 2024 implementing Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in Syria

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next